Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 4
4 · NATURES SUNSHINE PRODUCTS INC · Filed Oct 15, 2024
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2024-10-08$13.13/sh−1,800$23,634→ 74,163 total(indirect: by Fosun Industrial Co., Limited) - Sale
Common Stock
2024-10-11$13.37/sh−1,580$21,125→ 67,767 total(indirect: by Fosun Industrial Co., Limited) - Sale
Common Stock
2024-10-14$13.12/sh−1,300$17,056→ 66,467 total(indirect: by Fosun Industrial Co., Limited) - Other
Common Stock
2024-09-06+2,968→ 77,362 total(indirect: by Fosun Industrial Co., Limited) - Sale
Common Stock
2024-10-09$13.36/sh−1,816$24,262→ 72,347 total(indirect: by Fosun Industrial Co., Limited) - Sale
Common Stock
2024-10-01$13.54/sh−1,399$18,942→ 75,963 total(indirect: by Fosun Industrial Co., Limited) - Sale
Common Stock
2024-10-10$13.39/sh−3,000$40,170→ 69,347 total(indirect: by Fosun Industrial Co., Limited)
Holdings
- 2,854,607
Common Stock
Footnotes (2)
- [F1]These shares represent shares that were issued to Fosun Industrial Co., Limited upon the delivery of certain vested restricted stock units that were initially granted to a former director of the Issuer (the "Former Director"), as agreed between the Former Director and the Reporting Person.
- [F2]Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person.